Ticker
PCRXCompany Name
PACIRA BIOSCIENCES INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 134.52M | 19.06% | $ 705.85M |
3/31/2025 | $ 175.75M | 25.01% | $ 702.77M |
12/31/2024 | $ 189.39M | 27.02% | $ 700.97M |
9/30/2024 | $ 203.84M | 29.33% | $ 694.96M |
6/30/2024 | $ 194.36M | 28.16% | $ 690.31M |
3/31/2024 | $ 184.62M | 27.08% | $ 681.75M |
12/31/2023 | $ 154.65M | 22.91% | $ 674.98M |
9/30/2023 | $ 149.1M | 22.4% | $ 665.69M |
6/30/2023 | $ 147.32M | 22.01% | $ 669.23M |
3/31/2023 | $ 133.63M | 19.97% | $ 669.17M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for PACIRA BIOSCIENCES INC is calculated as follows: CF - Operations [ $ 56.27M ] / Revenues [ $ 421.1M ]
(=) OCF % [ 13.36% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.12% |